Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-07-12
1993-11-09
Fan, Jane T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546271, C07D41304, C07D41704
Patent
active
052603210
ABSTRACT:
Use of calcium antagonists of formula I ##STR1## wherein the substituents have various significances in the treatment of conditions related directly or indirectly to ionized calcium levels in the blood and combinations of calcium antagonists, e.g. of formula I, with calcitonins.
REFERENCES:
patent: 4442112 (1984-04-01), Muller-Schweinitzer
patent: 4466972 (1984-08-01), Neumann
patent: 4607041 (1986-08-01), Baxter et al.
Current Therapeutics, vol. 24, No. 12, pp. 13-23 (1983).
Drugs of the Future, vol. 8, No. 2, pp. 136 & 137 (1983).
Habib et al. Circ. Res. 58: 305-309, 1986.
Van Valen et al. Fed. Proc. 44 (3), 1985, No. 1909.
Day et al. Lab. Animal Science vol. 27, No. 5, pp. 817-821, 1977.
Family Medical Guide Cooley, pp. 122-124, 1980.
The World Book Illustrated Home Medical Encyclopedia, vol. one, p. 81, 1961.
Azria Moise
Hof Robert P.
Borovian Joseph J.
Fan Jane T.
Honor Robert S.
Kassenoff Melvyn M.
Sandoz Ltd.
LandOfFree
Use of 1,4-dihydropyridine derivatives and combinations thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of 1,4-dihydropyridine derivatives and combinations thereof , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of 1,4-dihydropyridine derivatives and combinations thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1143116